For Members
EMIG members' medical industry knowledge must be current in a landscape that is constantly changing. Through the EMIG platform, our online and in-person events, members can network and exchange information.
What is the EMIG platform?
Our exclusive platform enhances your membership with a personalised dashboard that provides easy access to:
Network
Submit questions or requests anonymously to the Network and receive curated responses, or search the directory for previously asked questions
Events
View and register for upcoming events by interest group, track your personal event schedule, and join live sessions directly through the platform
Resources
Quick access to documents, videos, and podcasts
Featured Network Questions
Tap into the collective expertise of the EMIG network. Browse recent questions and curated responses, or submit your own inquiries to connect with industry peers.
We're a small UK company looking for flexible, small marketing agencies to collaborate with for 2027.
We're looking for a marketing contractor for a 6-9 month contract.
Irish based pharmaceutical company seeking live distribution and co-marketing opportunities across UK and EU.
This is with respect to the question on "Breaking down barriers in the workplace pharmaceutical industry"
Featured Events
Below are upcoming events that may be relevant to EMIG members, register your attendance now.
EMIG Patient Organisation webinar
Zoom WebinarHosted by: EMIGAgenda: Co-creating conceptual, implementable, and transactable solutions and calls to action Webinar #3 will focus on the key areas of convergence, divergence and consensus-building.
EMIG Environmental Sustainability Meeting online
Zoom WebinarHosted by: EMIGAgenda: Environmental sustainability is a large topic. Many companies have asked: "Do I need to report this, and if I don't, why should I? What is the value to the organisation?" The answer to this question is 'WHY' the Environmental Sustainability and Commercial Strategy Group at EMIG was created. In this session we will cover (guest speaker to be announced): Forthcoming policy changes and what you need to know The pros / cons of reporting; even if not mandatory Establish a core group to create a Policy toolkit to support EMIG members. Open discussion Please register for this highly interactive F2F session that is designed to address one of the more complicated areas impacting all parts of the business.
Environmental Sustainability Special Interest Group
London
Hosted by: EMIGAgenda: Update on legislation on environmental sustainability
EMIG Patient Organisation meeting - Presentation of findings and final recommendations
LondonHosted by: EMIGAgenda: Presentation of findings and final recommendations
Featured Resources
Our resources library offers easy access to useful materials including presentations, documents, videos and podcasts. The resources are organised by most recent date upload but you can sort, filter and search by the name of the event, category or file type.
Commercial
UK FRN Single National Pharmacy Report
Commercial
UKFRN Future Pharmacy Report
Commercial
UKFRN 10 Year Plan report
Special Interest Groups
We have 14 SIGs which reflect the myriad demands on the professionals that are vital to a successful biopharmaceutical company. SIGs meet quarterly and inform EMIG members' views on a wide range of issues, from regulation and research to pricing and orphan diseases.
Each group has a chair, and determines the content of each meeting agenda.
EMIG is represented on the following:
DHSC
The Department of Health & Social Care in London is a ministerial department responsible, inter alia, for England's NHS, the health of the nation and access to medicines. EMIG works closely with the Department on issues such as medicines supply and pricing.MHRA
The Medicines and Healthcare Regulatory Authority is responsible to the DHSC for ensuring that medicines and medical devices in the UK work and are acceptably safe. EMIG works closely with the MHRA, HTA agencies and the NHS to ensure the prompt availability of new medicines to patients.AWTTC
The All Wales Therapeutics and Toxicology Centre advise on new medicines to ensure they are used effectively and appropriately in Wales and EMIG has a seat on the AWTTC Committee.EUCOPE
The European Confederation of Pharmaceutical Entrepreneurs has been the voice of small and mid-sized pharmaceutical and biotech companies in Europe for the last 15 years. EMIG has been part of EUCOPE from the outset and Leslie Galloway is Vice president of the Board.
Our Priorities
A healthy life sciences sector
- 1Driving the opportunities that the VPAG agreement offers the NHS
- 2Supporting a vibrant research community
- 3Expanding a large and highly skilled manufacturing sector
- 4A concentration of leadership and commercial expertise
- 5Ensuring a flexible and supportive licensing and reimbursement process
- 6A sophisticated and world-beating life sciences support services sector
- 7A connected regulatory, HTA and reimbursement process to accelerate patient access
Support the rebuild of the UK and NHS
- Illustrate the benefits of the VPAG Agreement £400m Industry Investment Facility to stakeholders
- Persuade global decision makers to invest in the UK
- Ensure innovative medicines reach UK patients
- Demonstrate how the implementation of the VPAG can support NHS affordability
Enable
...a vibrant research and development community through advocating for the creation of a life sciences sector research collaborative.
Encourage
...the building of a large and highly skilled manufacturing sector by pressing for capital investment allowances and tax credits at competitive levels.
Develop
...a concentration of commercial expertise and encourage global pharmaceutical HQs to locate their commercial centres in the UK.
Accelerate
...patient access to innovative medicines by developing marketing authorisation and health technology assessment in parallel, where companies opt to do so.
Leverage
...the life science sector's support services of the future through the UK's reputation for world-leading HTA assessment.